03 · What You Need to Know
How Scientific Value Changes the Ethical Justification of Risk
Research Risk Requires Something Worth Learning
Research involving humans asks people to accept procedures, burdens, uncertainty, or possible harm partly so that knowledge can be produced. That creates an ethical requirement that the expected knowledge be sufficiently valuable to justify asking people to bear those exposures.
CIOMS makes this explicit: imposing research risks requires social and scientific value. It also requires researchers, sponsors, and research ethics committees to ensure that risks are minimized and appropriately balanced against potential individual benefit and the social and scientific value of the research.
The Belmont Report similarly recognizes benefits to society through knowledge gained from research while emphasizing protection against harm to participants.
So the importance of knowledge is not an optional bonus added after risk assessment. It is part of the ethical reason for exposing participants to research risk in the first place.
Scientific Importance and Scientific Validity Are Different Questions
A research question may be extraordinarily important while the proposed study is incapable of answering it.
Suppose investigators study a major public-health problem using a sample too small to answer the primary question, invalid measurements, or an analysis that cannot support the intended inference. The importance of the topic does not rescue the design. Participants may still bear risk, but the promised knowledge becomes unlikely to materialize.
This is why ethical assessment should ask not only whether the question matters but also whether this study can answer it credibly. HHS advisory guidance on uninformative research makes the connection explicit: risk cannot be justified by activities that produce neither direct benefit nor knowledge, and the importance of the research question is relevant to the permissible risk.
Scientific or social importance
How valuable would a reliable answer to the research question be?
Scientific validity
Is the proposed study sufficiently rigorous to produce an informative answer?
Researchers need both. An important question investigated through an uninformative design does not generate the value needed to justify participant exposure.
Greater Importance Does Not Create an Unlimited Risk Budget
It is tempting to imagine a sliding scale: the more important the knowledge, the more participant risk becomes permissible. There is some truth in the idea that value matters to justification, but the relationship is constrained.
The 2024 Declaration of Helsinki states that medical research involving human participants may be conducted only when the importance of the objective outweighs the risks and burdens to participants. It also requires risks and burdens to be minimized, continuously monitored, assessed, and documented.
The Belmont Report goes further in identifying limits. It states that brutal or inhumane treatment is never morally justified and that significant risk of serious impairment demands especially strong justification.
Important knowledge therefore contributes to justification within ethical boundaries. It does not erase those boundaries.
Risk Minimization Comes Before Appealing to Importance
A researcher should not say, “This procedure is risky, but the question is extremely important,” before asking whether the same question can be answered with less risk.
The Belmont Report states that risks should be reduced to those necessary to achieve the research objective and that alternative procedures should be considered. The Declaration of Helsinki likewise requires measures to minimize risks and burdens.
This creates an important sequence:
Establish value
Is the research question sufficiently important to justify involving human participants?
Establish scientific validity
Can the study realistically produce reliable and useful knowledge?
Minimize exposure
Can the objective be achieved with fewer, safer, or less burdensome procedures?
Judge the residual risk
Only then ask whether the risk that remains is justified by potential participant benefits and the scientific and social value of the research.
The detailed logic of conducting a risk-benefit assessment therefore begins before the final balancing judgment.
Direct Benefit Changes the Ethical Structure
One of the most consequential distinctions is whether the risky procedure itself offers a prospect of benefit to the participant.
CIOMS recommends evaluating individual research interventions and procedures. For an intervention that offers potential individual benefit, the risks may be justified partly by that prospect of benefit. For procedures that offer no potential individual benefit, justification rests differently, particularly on the scientific and social value of the knowledge obtained and on applicable limits on risk.
Consider an experimental treatment that could help a participant with a serious disease and an additional biopsy performed solely to obtain research specimens. They occur in the same protocol, but their ethical justifications are not identical. The possible therapeutic benefit of the experimental intervention should not automatically be used to justify every research-only procedure attached to the trial.
Evaluate the Risky Procedure, Not Just the Study as a Whole
A valuable study can contain an unnecessary or disproportionately risky procedure.
Imagine a potentially important clinical trial that also includes an invasive exploratory procedure. If that procedure offers participants no prospect of benefit and contributes only marginally useful information, the importance of the main trial does not automatically justify it.
This procedure-level perspective prevents a kind of ethical bundling in which a compelling overall research objective provides cover for exposures that would be difficult to justify on their own.
Who Bears the Risk Matters
Two studies can promise the same valuable knowledge while raising different ethical concerns because different people bear the risk.
The Belmont Report emphasizes that risks and benefits affecting the immediate research participant normally carry special weight. It also identifies additional concern when vulnerable populations are involved.
The Declaration of Helsinki requires attention to how benefits, risks, and burdens are distributed and provides additional protections for individuals, groups, and communities in situations of vulnerability.
Researchers should therefore ask not only whether society could gain valuable knowledge, but also whether it is fair and ethically permissible for these participants to bear the risks required to obtain it.
Voluntary Consent Matters, but It Does Not Make Every Risk Permissible
Competent adults may voluntarily accept meaningful risks for reasons that matter to them, including altruistic reasons. The 2024 revision process for the Declaration of Helsinki expressly recognized that participants sometimes make freely chosen decisions to take risks for the good of others with little expectation of personal benefit.
But voluntariness is not the only ethical requirement. Research ethics committees still assess whether the study itself is ethically permissible. A signed consent form cannot transform an unnecessarily dangerous or inadequately justified protocol into acceptable research.
There Is No Universal Maximum Risk for “Important” Research
Researchers sometimes look for a threshold such as “twice minimal risk” or a percentage probability beyond which societal value can no longer justify exposure. Major general ethical frameworks do not supply a single numerical ceiling applicable to all research.
The appropriate limit depends partly on what the procedure offers the participant and which population is involved. Additional regulatory protections may impose specific limits in research involving children or other populations. The ethical analysis may therefore change even when the scientific question remains identical.
Watch Out
Do not invent a numerical risk threshold when the applicable framework does not provide one. Precision in a probability estimate is useful when evidence supports it, but an exact number does not by itself answer whether exposing participants to that risk is ethically permissible.
Social Value Should Be Specific, Not Ceremonial
“This study will contribute to knowledge” is true of almost every research proposal in aspiration. It is not yet a meaningful account of social or scientific value.
Ask what uncertainty the study addresses, who could use the resulting knowledge, whether the answer could plausibly change understanding or practice, and whether similar evidence already exists. If the study merely duplicates established knowledge without a defensible reason, its value may be weaker than the protocol suggests.
The stronger the risks imposed on participants, the less satisfactory vague claims about contribution become. Ethical justification should rest on knowledge that may reasonably be expected from the actual design, not the most optimistic imaginable future impact.
Some Risks May Remain Unacceptable Despite Valuable Knowledge
The most important implication is easy to lose: there are limits to what researchers may ask individuals to bear for others.
Belmont explicitly rejects brutal or inhumane treatment and calls for extraordinary scrutiny when serious impairment is possible. The Declaration of Helsinki requires researchers to be confident that risks and burdens can be satisfactorily managed and requires reconsideration when they outweigh potential benefits.
The harder question of whether societal benefit can justify substantial risk to individual participants therefore cannot be answered simply by increasing the estimated value of the knowledge until the equation appears favorable.
04 · A Practical Example
When an Important Question Does Not Justify Every Procedure
Hypothetical Example
A Trial for a Serious Disease With an Optional Research Biopsy
Researchers test a promising intervention for a serious disease with limited treatment options. The trial could answer an important clinical question. Investigators also propose an additional invasive biopsy solely to explore a secondary biological mechanism. The biopsy offers participants no prospect of direct clinical benefit.
Separate the procedures
The experimental intervention and research-only biopsy should not be treated as though they have exactly the same ethical justification.
Assess potential benefit
The experimental intervention may offer a prospect of benefit to participants. The biopsy does not.
Examine knowledge value
The researchers assess how important the biopsy data are to the scientific objectives rather than relying on the importance of the disease as a whole.
Minimize the biopsy risk
They consider whether stored specimens, less invasive sampling, fewer biopsies, or other methods could provide scientifically adequate information.
Judge what remains
The residual risk of the research-only biopsy must be justified by the value of the information it produces under the applicable ethical framework. The potential benefit of the experimental treatment does not simply absorb the biopsy's risk.
The study's overall importance matters, but ethical analysis becomes more precise when researchers ask what each risky procedure contributes and what, if anything, participants stand to gain from that particular exposure.
